Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
February 15, 2011
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group
Andrew Wirth, Andrew Grigg, Max Wolf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome
Nigel Spry, Jennifer Harvey, Craig Macleod, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2017
Treatment Outcomes from <sup>68</sup>Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
Louise Emmett, Pim J van Leeuwen, Rohan Nandurkar, et al.
Medical Physics
|
January 8, 2015
The first clinical treatment with kilovoltage intrafraction monitoring (KIM): a real-time image guidance method
Paul J Keall, Jin Aun Ng, Ricky O'Brien, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 10, 2019
Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group
Hester Lieng, Andrew Kneebone, Amy J Hayden, et al.
BJU International
|
April 29, 2022
Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups
Matthew J Roberts, Mark D Chatfield, George Hruby, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 31, 2007
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy
Kirsty L Wiltshire, Kristy K Brock, Masoom A Haider, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2017
The Impact of <sup>68</sup>Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J Roach, Roslyn Francis, Louise Emmett, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 25, 2018
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group
Hester Lieng, Amy J Hayden, David R H Christie, et al.
Frontiers in Oncology
|
October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
February 15, 2011
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group
Andrew Wirth, Andrew Grigg, Max Wolf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome
Nigel Spry, Jennifer Harvey, Craig Macleod, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2017
Treatment Outcomes from <sup>68</sup>Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
Louise Emmett, Pim J van Leeuwen, Rohan Nandurkar, et al.
Medical Physics
|
January 8, 2015
The first clinical treatment with kilovoltage intrafraction monitoring (KIM): a real-time image guidance method
Paul J Keall, Jin Aun Ng, Ricky O'Brien, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 10, 2019
Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group
Hester Lieng, Andrew Kneebone, Amy J Hayden, et al.
BJU International
|
April 29, 2022
Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups
Matthew J Roberts, Mark D Chatfield, George Hruby, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 31, 2007
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy
Kirsty L Wiltshire, Kristy K Brock, Masoom A Haider, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2017
The Impact of <sup>68</sup>Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J Roach, Roslyn Francis, Louise Emmett, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 25, 2018
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group
Hester Lieng, Amy J Hayden, David R H Christie, et al.
Frontiers in Oncology
|
October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Page
of 13